-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
DiaMedica Therapeutics Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2018 to 2024.
- DiaMedica Therapeutics Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $7 K, unchanged year-over-year.
- DiaMedica Therapeutics Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was $43 K, a 53.6% increase year-over-year.
- DiaMedica Therapeutics Inc. annual Income Tax Expense (Benefit) for 2023 was $43 K, a 53.6% increase from 2022.
- DiaMedica Therapeutics Inc. annual Income Tax Expense (Benefit) for 2022 was $28 K, unchanged from 2021.
- DiaMedica Therapeutics Inc. annual Income Tax Expense (Benefit) for 2021 was $28 K, a 3.7% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)